Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ACADIA PHARMACEUTICALS INC | Director | Common Stock | 20.2K | $341K | $16.94 | May 29, 2024 | Direct |
Pacira BioSciences, Inc. | Director | Common Stock | 17.6K | $225K | $12.81 | Aug 16, 2024 | Direct |
ACADIA PHARMACEUTICALS INC | Director | Restricted Stock Units | 9.39K | $159K | $16.94 | May 29, 2024 | Direct |
Mirum Pharmaceuticals, Inc. | Director | Restricted Stock Units | 5.7K | $146K | $25.68 | Jun 5, 2024 | Direct |
Edgewise Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 20.6K | Jun 10, 2024 | Direct | ||
ACADIA PHARMACEUTICALS INC | Director | Director Stock Options (Right to Buy) | 16K | May 29, 2024 | Direct | ||
Pacira BioSciences, Inc. | Director | Stock Option (Right to Buy) | 12.2K | Jun 12, 2024 | Direct | ||
Mirum Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 8.78K | Jun 5, 2024 | Direct |